Indefinite Delivery Contract HT942523D0019
- Not listed
- This Other Transaction IDV, awarded to Bavarian Nordic A/S on December 22, 2022, by the Joint Program Executive Office for Chemical and Biological Defense under the Department of the Army Acquisition Support Center, carries a ceiling value of $95.7 million with no set-aside provisions. The contract vehicle establishes a prototype development framework for the Medical Viral Aerosol Wheeled Encapsulated Endotracheal Ventilator (WEEV) system and advancement of the company's Eastern equine...
- This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the German biotechnology company IDT Biologika GMBH. The $80,000,000 multiple award contract is for manufacturing and characterization services for vaccines and other biologics for infectious disease research and pandemic preparedness efforts. Task orders issued under the contract include influenza virus human challenge...
- Emory University was awarded a single-award indefinite delivery contract by the Defense Health Agency (DHA) to provide services for the generation of monoclonal antibodies (mAbs) for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a potential value of $763,502 and runs through September 2025. Under this IDV, Emory has received two firm fixed price delivery orders to date. The first, valued at $309,001, is for clinical trial research services...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract valued at $26.77 million to the National Academy of Sciences (NAS), a nonprofit scientific advisory organization, to support the U.S. Army Medical Research Development Command (USAMRDC) Research Associateship Program through February 29, 2028. The contract operates on a cost-no-fee basis with no set-asides applied. The IDV serves as the overarching vehicle through which the Defense Health Agency procures administrative...
- This indefinite delivery contract was awarded by the Department of the Army Medical Command to Eagle Applied Sciences, LLC, a minority-owned small business, as a multiple-award contract under the competitive 8(a) set-aside program. The contract established a potential value of $249 million for research and development support services to be ordered on an as-needed basis by the U.S. Army Medical Research Institute of Infectious Diseases from November 2015 to May 2021. Two task orders have been...
- Euroimmun US Incorporated, a wholly owned subsidiary of Revvity Inc., was awarded a single-award Indefinite Delivery Contract by the Department of the Army Medical Command valued at $2.4 million with a performance period extending through January 3, 2029. The contract, issued without set-aside provisions on January 4, 2024, encompasses the supply of immunodiagnostic systems reagents and supplies. These products support the Army's medical diagnostic and testing capabilities, providing essential...
- This Indefinite Delivery Contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on July 1, 2025, establishes a multiple-award vehicle with Bavarian Nordic, Inc. for the procurement of adult vaccines with a contract ceiling of $9.433 million and a period of performance extending through June 30, 2026. The contract is issued without set-aside restrictions and represents a civilian procurement supporting the CDC's vaccine acquisition needs. As a biotechnology company...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Sr-Services GMBH, a German-based for-profit company. The contract, valued at $166,686.64, is for the procurement of sensor cartridges for the detection of biological agents, lysergic acid diethylamide, and methamphetamine. Under this IDC, two firm fixed-price delivery orders have been issued to Sr-Services GMBH. The first order, valued at $49,971.44, is for the...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA) to Bioscientia Institut FÜR Medizinische Diagnostik GMBH, a for-profit medical diagnostics laboratory based in Germany. The single-award IDC has a ceiling value of $690,476.25 and a period of performance through April 2025. The contract aims to provide clinical reference laboratory testing services to support the healthcare missions of the DHA and the Department of the Army Medical Command at the Landstuhl...
- This indefinite delivery contract was awarded by the Defense Health Agency (DHA), a defense agency, to Diasorin Deutschland GMBH, a foreign-owned, for-profit manufacturer of medical products. The contract has a ceiling value of $732,571.15 and a period of performance through September 4, 2028. It is a single-award contract that does not utilize any set-asides. The contract is for the provision of medical testing supplies and laboratory equipment, specifically the RPP NXTAG (IVD-US) 96 test kits,...
- HT942523D0019Indefinite Delivery Contract
- 1Federal Contract Awards
The Defense Health Agency awarded a single-award indefinite delivery contract to Bavarian Nordic A/S with a potential value of $245,070 to provide endpoint titer analysis services in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) through September 2028. A $45,000 firm fixed price delivery order against this contract tasks Bavarian Nordic to perform endpoint titer analysis services for USAMRIID from September 2023 through September 2024 in Denmark. Originally, the U.S. Army Medical Research Acquisition Activity posted a special notice of its non-competitive intent to award a sole-source contract to Bavarian Nordic. The notice indicated Bavarian Nordic would utilize its proprietary, validated assays to conduct laboratory investigation of the human response to vaccines through enzyme-linked immunosorbent assay and plaque reduction neutralization testing of serum samples. These services support USAMRIID's on-site and off-site clinical research and trials for the Division of Medicine Department of Clinical Research concerning biological defense against infectious diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/21/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HT942523D0019-HT942523F0374 | Bavarian Nordic A / S | $0 | 9/29/23 | 9/28/24 | 5/23/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Vaccinia End-Point Titers | HT9425-23-R-0094 | Defense Health Agency | Special Notice 1/1 | 7/21/23, 3:09 PM |